Goldman Slashes Tesla Delivery Estimates On Weak Monthly Trends
Goldman Sachs analysts cut Tesla’s delivery forecasts, slashed earnings estimates, and scaled back expectations for brand momentum across key markets. The message is clear: demand is weakening, competition is accelerating, and consumer enthusiasm is fading. This sentiment is also shared with UBS.
“We’re lowering our Tesla vehicle delivery assumptions and EPS estimates to better reflect weaker monthly datapoints in key regions (e.g. China, the US, and Europe), and also consumer survey data on Tesla (per HundredX and Morning Consult),” analysts Mark Delaney, Dan Duggan, and others wrote in a note to clients on Thursday.
The analysts revised their outlook and now expect 2Q25 deliveries to come in at just 365,000 units, a sharp downgrade from the prior 410,000 estimate—and well below Visible Alpha Consensus data of 417,000.
Industry and registration data through May show continued year-over-year declines across key global markets, including the US, China, and Europe.
Full-year delivery estimates were also slashed:
-
2025: cut from 1.70 million to 1.575 million
-
2026: cut from 1.95 million to 1.865 million
-
2027: cut from 2.20 million to 2.15 million
The analysts also cut their earnings estimates, citing softer sales volumes as a key drag on profitability:
-
2025: $1.10 (was $1.25)
-
2026: $2.05 (was $2.15)
-
2027: $3.00 (was $3.10)
Translation so far from the analysts: “We remain Neutral rated on TSLA shares. We lower our 12-month price target to $285 from $295 prior.”
To gauge consumer sentiment, analysts cited data from HundredX and Morning Consult, which showed declines in Tesla’s brand buzz and purchase intent across North America and Europe. Sentiment remains particularly weak in Canada, France, Germany, and the UK, while China stands out as the lone bright spot.
Goldman’s outlook echoes UBS’ take from last week, which warned that global enthusiasm for the Tesla brand is waning. Both firms maintained a cautious stance on the stock.
“Overall, we remain cautious on Tesla stock,” UBS analyst Joseph Spak said in the note. UBS maintains a Sell rating with a 12-month price target of $190.
Meanwhile, Daniel Ives of Wedbush Securities recently raised his 12-month price target on Tesla to a Street-high $500 from $350, citing the near-term launch of Tesla’s autonomous ride-hailing Cybercabs as a major catalyst to spark the “golden age of autonomy.”
Tyler Durden Fri, 06/06/2025 – 08:05
Source: https://freedombunker.com/2025/06/06/goldman-slashes-tesla-delivery-estimates-on-weak-monthly-trends/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
